CLASS I ONGOING Device recall · Reported 8 Feb 2023 · FDA Enforcement Report

CADD Administration Set, List Numbers: a) recalled by Smiths Medical ASD

Smiths Medical ASD is recalling CADD Administration Set, List Numbers: a), distributed nationwide in the US. The recall was initiated on 9 Dec 2022 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesa) REF 21-7346-24: UDI/DI 35019517161957; Lot Numbers: 3776356 through 4320785; b) REF 21-7363-24: UDI/DI 3501951716196; Lot Numbers: 3773412 through 4334343;
Quantity recalled1616714 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0962-2023
FDA event ID
91392
Recalling firm
Smiths Medical ASD, Minneapolis, MN
Classification
Class I
Status
Ongoing
Recall initiated
9 Dec 2022
FDA classified
30 Jan 2023
Reported
8 Feb 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Infusion Pumps

Timeline

9 Dec 2022Recall initiated by company
30 Jan 2023Classified by FDA+52 days
8 Feb 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There are two potential issues with CADD Infusion System Infusion Sets: (1) Lack of Delivery or Underdelivery related to Tubing Occlusion and (2) False "No Disposable Attached (NDA)" Alarms

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

CADD Administration Set, List Numbers: a) REF 21-7346-24; b) REF 21-7363-24

Where it was distributed

Worldwide Distribution: US (nationwide) and OUS countries of: CH, CA, ES, FR, AT, BE, IT, DK, NO, EE, DE, NL, AU, GB, SE, PL, SA, IN, IL, PT, CZ, IE, NZ, LU, SI, ZA, BM, SG, MQ, CL, LB, MY, HU, JP, TW, and CN

Nationwide CaliforniaDelawareIllinoisIndiana

Questions about this recall

Is CADD Administration Set, List Numbers: a) recalled?

Yes. Smiths Medical ASD recalled CADD Administration Set, List Numbers: a) on 9 Dec 2022. The recall is Class I and its status is Ongoing. Recall number Z-0962-2023.

Why was it recalled?

There are two potential issues with CADD Infusion System Infusion Sets: (1) Lack of Delivery or Underdelivery related to Tubing Occlusion and (2) False "No Disposable Attached (NDA)" Alarms

Which lots are affected?

a) REF 21-7346-24: UDI/DI 35019517161957; Lot Numbers: 3776356 through 4320785; b) REF 21-7363-24: UDI/DI 3501951716196; Lot Numbers: 3773412 through 4334343;

Where was it sold?

Worldwide Distribution: US (nationwide) and OUS countries of: CH, CA, ES, FR, AT, BE, IT, DK, NO, EE, DE, NL, AU, GB, SE, PL, SA, IN, IL, PT, CZ, IE, NZ, LU, SI, ZA, BM, SG, MQ, CL, LB, MY, HU, JP, TW, and CN

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Smiths Medical ASD

All 284

Other Infusion Pumps recalls

All 546